We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2866:HKEXCOSCO SHIPPING Development Co., Ltd. Class H Analysis

Data as of 2026-03-17 - not real-time

HK$1.19

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

COSCO SHIPPING Development is trading at HK$1.19, comfortably above its 20‑day SMA (1.213) and well within a bullish SMA hierarchy (20‑day > 50‑day > 200‑day), suggesting an underlying uptrend. RSI sits at 49, indicating neutral momentum, while the MACD histogram is slightly negative, hinting at short‑term bearish pressure. The stock’s PE ratio of 8.5 is dramatically lower than the industry average of 29.4, and a PB of 0.45 underscores a deep valuation discount. Dividend yield remains attractive at 3.77% with a payout ratio under 50%, supporting income‑focused investors. However, the company faces significant balance‑sheet stress: a debt‑to‑equity of over 300%, cash of HK$12.5B versus debt of HK$93.8B, and negative free cash flow of HK$7.4B, all while revenue has slipped 9.9% year‑on‑year. Volatility is high at nearly 88% over the past 30 days, but beta is low (≈0.2), implying limited market‑wide correlation.
Given the “Extreme Greed” sentiment (fear‑greed index 81.5) and stable trading volume, the stock appears undervalued and dividend‑rich, yet the leverage and cash‑flow constraints pose material risks. Investors should weigh the attractive valuation and yield against the debt load and earnings pressure when deciding on positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish SMA alignment supporting near‑term price stability
  • Attractive dividend yield of 3.77%
  • Negative MACD histogram indicating short‑term downside risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant debt‑to‑equity ratio limiting financial flexibility
  • Undervalued multiples (PE 8.5 vs industry 29.4)
  • Stable dividend payout with moderate payout ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Deep valuation discount and low price‑to‑book
  • Sustainable dividend income supporting total return
  • Potential upside if leverage is reduced and cash flow improves

Key Metrics & Analysis

Financial Health

Revenue Growth-9.90%
Profit Margin6.21%
P/E Ratio8.5
ROE5.53%
ROA1.82%
Debt/Equity301.55
P/B Ratio0.5
Op. Cash FlowHK$5.0B
Free Cash FlowHK$-7363677696
Industry P/E29.4

Technical Analysis

TrendBullish
RSI49.2
SupportHK$1.08
ResistanceHK$1.71
MA 20HK$1.21
MA 50HK$1.14
MA 200HK$1.14
MACDBearish
VolumeStable
Fear & Greed Index81.48

Valuation

GradeUndervalued
TypeBlend
Dividend Yield3.77%

Risk Assessment

Beta0.20
Volatility87.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.